The direct answer

Transplanted hair is permanent because the follicles are donor-dominant — taken from the back and sides of the scalp, which are genetically resistant to DHT-driven androgenetic hair loss. These follicles continue producing hair for a lifetime, including going through normal ageing (greying, slight thinning) like any other hair.

However, the overall appearance of a hair transplant is not permanent in the same sense. The surrounding non-transplanted hair continues to be vulnerable to pattern loss. Without management (finasteride, minoxidil), a hair transplant done at age 30 may look less full at age 45 — not because the transplanted hair has failed, but because the native hair around it has continued to thin.

The science of donor dominance

Androgenetic alopecia (male pattern baldness) is driven by follicle sensitivity to dihydrotestosterone (DHT). This sensitivity is genetically encoded at the individual follicle level:

  • Hair follicles at the top and front of the scalp (the bald pattern) are DHT-sensitive
  • Hair follicles at the back and sides (donor area) are DHT-resistant

This is why balding men retain hair in a horseshoe pattern — the back and sides are genetically different from the top. When a follicle from the donor area is transplanted to the recipient area, it keeps its donor characteristics. It does not become DHT-sensitive just because its location has changed.

This is the foundational biological principle of hair transplant surgery, established by Dr Norman Orentreich in 1959 and confirmed by 65+ years of clinical experience.

What the 12-month result looks like in 5, 10, 20 years

At 12 months

  • 95%+ of transplanted hairs are producing visible hair at final density
  • Hairline is established
  • Result looks natural (with competent surgery)

At 5 years

  • Transplanted hair unchanged in density
  • Possible progression of native hair loss in adjacent areas
  • If on finasteride: little to no visible change from 12-month result
  • If not on finasteride and you have active androgenetic loss: visible thinning behind or around the transplanted zone

At 10–15 years

  • Transplanted hair still present but some may show normal age-related thinning (like any hair)
  • Native hair may have significantly progressed in androgenetic loss patterns
  • Many patients at this stage consider a second procedure to cover new thinning areas

At 20+ years

  • Transplanted hair remains visible and growing
  • Greying follows the donor area's timing
  • Aggregate density may be lower due to general age-related hair thinning
  • Original result remains fundamentally intact; the context around it has changed

When a second transplant becomes relevant

Not everyone needs a second procedure. Patients most likely to need one:

  1. Younger patients (under 35) with active androgenetic loss. Pattern is still evolving — additional transplanted areas may be needed as new loss develops.
  2. Patients who skip finasteride. Continued native hair thinning changes the appearance of the result.
  3. Aggressive first procedures. A patient who wanted very high density on a young hairline may need to adjust as the overall density of the scalp shifts.
  4. Large donor reserves used cautiously in the first procedure. Some surgeons deliberately stage work over two sessions — this is a planning choice, not a failure.

Most second procedures are 1,000–2,500 grafts — smaller than a first procedure, filling specific new thinning areas or adding density.

What can cause transplanted hair to fail

Rare but possible:

  • Poor graft handling during surgery. Grafts out of the body for too long, stored at wrong temperature, or damaged during extraction may fail to establish. This shows up in the first 3–6 months.
  • Unrecognised scarring alopecia. A small subset of patients have scarring conditions (lichen planopilaris, frontal fibrosing alopecia) that destroy transplanted follicles just as they destroy native hair. Pre-surgery screening should catch this; occasionally it does not.
  • Severe complications. Infection, necrosis, or trauma to the recipient area in the early post-op period.

After 12 months of established growth, transplanted hair has essentially the same life expectancy as the donor area hair it came from.

The role of finasteride and minoxidil

For androgenetic cases (the vast majority of hair transplant patients), continuing finasteride (1mg daily, prescription) and often minoxidil (5% topical, over-the-counter) after surgery serves a specific purpose: it protects the non-transplanted hair, not the transplanted hair.

Stopping finasteride after a transplant typically means:

  • Gains in the non-transplanted hair are lost over 6–18 months
  • Continued pattern loss progression
  • The transplanted hair remains, but surrounded by continued thinning

Most UK surgeons recommend indefinite finasteride use for male patients after transplant. Side-effect profiles should be discussed with a GMC-registered doctor — sexual side effects occur in ~1–2% of users and are the primary reason for discontinuation.

Norwood progression and long-term planning

A 25-year-old at Norwood 2 who has a hairline transplant has very different long-term expectations from a 55-year-old at Norwood 5 who has full restoration.

Younger patients:

  • More likely to need a second procedure
  • Essential to be on pharmacological maintenance
  • Conservative density planning on the first procedure leaves donor reserves for later
  • Hairline design should account for the likely future temples and crown thinning

Older patients:

  • Pattern is often stable — less likely to need a second procedure
  • Donor reserves can be used more fully in the first procedure
  • Finasteride may be optional depending on remaining hair

Good surgeons plan the first procedure with the second in mind. Aggressive first procedures on young patients with ongoing loss are the most common cause of suboptimal long-term outcomes.

Internal links

Disclaimer

This content is for information only and is not medical advice. Medication decisions (finasteride, minoxidil) should be made in consultation with a GMC-registered doctor. Individual outcomes vary. Consult a qualified surgeon for advice specific to your case. Medical reviewer: {{NEEDS MEDICAL REVIEWER}} — to be filled in before publication.